CD74 and neoplasm: To restore an effective immune response, we observed that mice receiving a combination of CD74 blockade and an immune checkpoint inhibitor (anti‐PD‐1) exhibited slower tumour growth and improved overall survival (Figure 7C–F; Figure S21A–E).